UCB SA(UCB.BR)— 技術面狀態
數據截至2026-09-21 — 每個交易日晚間對全部追蹤範圍重新計算。Closelook研究日記,不構成投資建議。
Trades -4.8% vs the 50-day and -13.3% vs the 200-day average, 26.4% below the 52-week high and +11.4% off the 52-week low; a death cross printed 30 sessions ago. Computed from daily closes.
移動平均線狀態
- 相對20日均線-0.3%
- 相對50日均線-4.8%
- 相對200日均線-13.3%
- 52週區間低於52週高點26.4% · 高於52週低點11.4%
- 連續走勢連續1個交易日上漲
- 均線交叉死亡交叉(30個交易日前)
- 50日均線交叉股價向下穿越50日均線(37個交易日前)
- 隨機指標%K 50.7 · %D 30.7
相關頁面: UCB.BR圖表與概覽 · 品質與財務體檢 · 訊號看板
FAQ · from the current data · as of 2026-09-21
Quick answers
UCB.BR目前的Closelook訊號是什麼?
Downtrend stack — Trades -4.8% vs the 50-day and -13.3% vs the 200-day average, 26.4% below the 52-week high and +11.4% off the 52-week low; a death cross printed 30 sessions ago. Computed from daily closes.(截至2026-09-21;訊號看板每個交易日晚間對全部追蹤範圍重新計算。研究日記讀數,不構成投資建議。)
UCB.BR目前是否位於50日與200日均線上方?
截至2026-09-21,UCB SA位於50日均線下方(-4.8%),200日均線下方(-13.3%);距20日均線-0.3%。
UCB.BR距52週高點有多遠?
截至2026-09-21,低於52週高點26.4%,高於52週低點11.4%。
Related in the Closelook universe
then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- ONC BeiGene, Ltd.industry
- REGN Regeneron Pharmaceuticals Incindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- MRNA Moderna Incindustry
- TWST Twist Bioscience Corpindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- RXRX Recursion Pharmaceuticals Incindustry
- HALO Halozyme Therapeutics Incindustry
- SMMT Summit Therapeutics PLCindustry
- GMAB Genmab ASindustry
- CRSP Crispr Therapeutics AGindustry
- IBRX Immunitybio Incindustry
- SRPT Sarepta Therapeutics Incindustry
- TGTX TG Therapeutics Incindustry
- EXEL Exelixis Incindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- INCY Incyte Corporationindustry